[1]刘永政,刘晓静,扈 洁,等.冠心病经皮冠状动脉介入术治疗前后患者血清肺炎衣原体抗体IgA、超敏C-反应蛋白、血管生成素-2变化及预后预测价值研究[J].陕西医学杂志,2024,(5):692-695.[doi:DOI:10.3969/j.issn.1000-7377.2024.05.026]
　LIU Yongzheng,LIU Xiaojing,HU Jie,et al.Changes of serum CP-IgA,hs-CRP and Ang-2 levels and their predictive value of prognosis in patients with coronary heart disease before and after percutaneous coronary intervention[J].,2024,(5):692-695.[doi:DOI:10.3969/j.issn.1000-7377.2024.05.026]
点击复制

冠心病经皮冠状动脉介入术治疗前后患者血清肺炎衣原体抗体IgA、超敏C-反应蛋白、血管生成素-2变化及预后预测价值研究
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2024年5期
页码:
692-695
栏目:
临床检验
出版日期:
2024-05-05

文章信息/Info

Title:
Changes of serum CP-IgA,hs-CRP and Ang-2 levels and their predictive value of prognosis in patients with coronary heart disease before and after percutaneous coronary intervention
作者:
刘永政1; 刘晓静1; 扈 洁2; 王俊侠1; 刘平原1; 刘淑华1
(1.秦皇岛市第一医院心内科,河北 秦皇岛 066000; 2.华北理工大学附属医院中医科,河北 唐山 063000)
Author(s):
LIU Yongzheng; LIU Xiaojing; HU Jie; WANG Junxia; LIU Pingyuan; LIU Shuhua
(Department of Cardiology,First Hospital of Qinhuangdao,Qinhuangdao 066000,China)
关键词:
冠心病;  经皮冠状动脉介入术;  肺炎衣原体抗体IgA;  超敏C-反应蛋白;  血管生成素-2;  预后
Keywords:
Coronary heart disease;  Percutaneous coronary intervention;  Chlamydia pneumoniae antibody-IgA;  Hypersensitive C-reactive protein;  Angiogenin-2;  Prognosis
分类号:
R 541.4
DOI:
DOI:10.3969/j.issn.1000-7377.2024.05.026
文献标志码:
A
摘要:
目的:探讨冠心病(CHD)经皮冠状动脉介入术治疗前后患者血清肺炎衣原体抗体IgA(CP-IgA)、超敏C-反应蛋白(hs-CRP)及血管生成素-2(Ang-2)变化及预后预测价值。方法:选取CHD患者135例为观察组,根据患者预后情况分为预后良好组(119例)及预后不良组(16例)。另选取同期体检健康者135例为对照组。比较观察组和对照组、观察组PCI前后以及两个亚组血清CP-IgA、hs-CRP及Ang-2水平。分析血清CP-IgA、hs-CRP及Ang-2与PCI术后CHD患者预后的相关性。分析血清CP-IgA、 hs-CRP及Ang-2对PCI术后CHD患者预后的预测价值。结果:观察组血清CP-IgA、hs-CRP及Ang-2水平高于对照组(均P<0.05)。观察组患者PCI术后血清CP-IgA及Ang-2水平较PCI术前降低,血清hs-CRP水平较PCI术前升高(均P<0.05)。预后良好组患者血清CP-IgA、hs-CRP及Ang-2水平低于预后不良组(均P<0.05)。血清CP-IgA、hs-CRP及Ang-2与PCI术后CHD患者预后呈正相关(均P<0.05)。血清CP-IgA、hs-CRP及Ang-2单独预测PCI术后CHD患者预后的曲线下面积(AUC)小于三项联合(均P<0.05)。结论:CHD患者血清CP-IgA、hs-CRP及Ang-2水平升高,PCI术后血清CP-IgA和Ang-2水平降低,hs-CRP水平升高。预后不良患者血清CP-IgA、hs-CRP及Ang-2水平升高,且三者联合对PCI术后CHD患者预后的预测价值较高。
Abstract:
Objective:To explore the changes of serum chlamydia pneumoniae antibody-IgA(CP-IgA),hypersensitive C-reactive protein(hs-CRP)and angiogenin-2(Ang-2)levels and their predictive value of prognosis in patients with coronary heart disease(CHD)before and after percutaneous coronary intervention(PCI).Methods: A total of 135 CHD patients were selected as the observation group,and divided into good prognosis group(119 cases)and poor prognosis group(16 cases)according to the prognosis of the patients.Another 135 healthy subjects were selected as control group.The serum levels of CP-IgA,hs-CRP and Ang-2 were compared between the observation group and the control group,before and after PCI in the observation group and two subgroups.The correlation between serum CP-IgA,hs-CRP and Ang-2 and prognosis of CHD patients after PCI was analyzed.The prognostic value of serum CP-IgA,hs-CRP and Ang-2 in patients with CHD after PCI was analyzed.Results: The levels of CP-IgA,hs-CRP and Ang-2 in the observation group were higher than those in the control group(all P<0.05).The serum CP-IgA and Ang-2 levels in observation group were decreased after PCI,and the serum hs-CRP level was increased after PCI(all P<0.05).The levels of CP-IgA,hs-CRP and Ang-2 in the good prognosis group were lower than those in the poor prognosis group(all P<0.05).Serum CP-IgA,hs-CRP and Ang-2 were positively correlated with the prognosis of CHD patients after PCI(all P<0.05).The area under the curve(AUC)of serum CP-IgA,hs-CRP and Ang-2 independently predicted the prognosis of CHD patients after PCI was smaller than that of the three combinations(all P<0.05).Conclusion:Serum CP-IgA,hs-CRP and Ang-2 levels are increased in CHD patients,while serum CP-IgA and Ang-2 levels are decreased and hs-CRP level is increased after PCI.Serum CP-IgA,hs-CRP and Ang-2 levels are increased in patients with poor prognosis,and the combination of these three levels has a higher prognostic value in patients with CHD after PCI.

参考文献/References:

[1] 郭晓梅,刘艳军,黄春莉.中药复方穴位贴敷联合心可舒片治疗冠心病心绞痛临床研究[J].陕西中医,2023,44(2):255-258.
[2] HOU Y,LI X,WANG X,et al.The effect of Huoxue Huayu decoction on restenosis after percutaneous coronary intervention in patients with coronary heart disease:A protocol for systematic review and meta-analysis[J].Medicine(Baltimore),2022,101(4):e28677.
[3] 程铭威,靳利利,史振羽,等.疏肝理脾方治疗冠心病经皮冠状动脉介入术术后焦虑抑郁状态疗效研究[J].陕西中医,2022,43(9):1208-1211,1259.
[4] 殷娟,姬超,尚晓娜,等.心脏介入手术对冠心病患者外周血hsCRP、IL-4及IL-10水平的影响[J].心血管康复医学杂志,2018,27(4):417-420.
[5] 赵燕茹,杨一鸣,潘思雨,等.高敏C反应蛋白/前白蛋白联合小而密低密度脂蛋白胆固醇对ACS患者PCI术后MACE的预测价值[J].临床心血管病杂志,2022,38(9):711-715.
[6] 喻茂文.血清Lp-PLA2、hs-CRP、D-二聚体水平与冠心病患者病情的相关性分析[J].医学临床研究,2021,38(3):349-351,355.
[7] 颜红兵.美国冠心病诊断与治疗指南[M].2版.北京:中国环境科学出版社,2006:240.
[8] 中华医学会心血管病学分会介入心脏病学组,中国医师协会心血管内科医师分会血栓防治专业委员会,中华心血管病杂志编辑委员会.中国经皮冠状动脉介入治疗指南(2016)[J].中华心血管病杂志,2016,44(5):382-400.
[9] TANAKA T,MIKI K,AKAHORI H,et al.Comparison of coronary atherosclerotic disease burden between ST-elevation myocardial infarction and non-ST-elevation myocardial infarction:Non-culprit Gensini score and non-culprit SYNTAX score[J].Clin Cardiol,2021,44(2):238-243.
[10] TABATABAEI M S,AHMED M.Enzyme-linked immunosorbent assay(ELISA)[J].Methods Mol Biol,2022,2508:115-134.
[11] 董昕,杨朋康.单硝酸异山梨酯联合维拉帕米对冠心病稳定型心绞痛患者血脂水平及血清同型半胱氨酸、高敏C反应蛋白的影响[J].陕西医学杂志,2020,49(4):485-488.
[12] OZTURK F,BARMAN H A,ASOGLU R,et al.Effect of coexistence of chlamydia pneumoniae and increased epicardial fat thickness on coronary artery disease[J].Eur Rev Med Pharmacol Sci,2021,25(5):2291-2298.
[13] DADASHI M,HAJIKHANI B,GHAZI M,et al.The global prevalence of chlamydia pneumoniae,helicobacter pylori,cytomegalovirus and herpes simplex virus in patients with coronary artery disease:A systematic review and meta-analysis[J].Microb Pathog,2021,152:104572.
[14] STATES R A,KRZAK J J,SALEM Y,et al.Instrumented gait analysis for management of gait disorders in children with cerebral palsy:A scoping review[J].Gait Posture,2021,90:1-8.
[15] KOWALCZEWSKI P ,OLEJNIK A,RYBICKA I,et al.Membrane filtration-assisted enzymatic hydrolysis affects the biological activity of potato juice[J].Molecules,2021,26(4):852.
[16] 许磊,张拓伟,王新冰,等.二维斑点追踪成像技术评价益气活血化瘀方改善冠脉介入术后患者左心室功能的研究[J].陕西中医,2021,42(9):1226-1228,1301.
[17] 徐宝华,李楠,朱家庭.冠状动脉粥样硬化性心脏病慢性心力衰竭患者血清microRNA-499水平及与心功能和心肌重构的相关性[J].中国现代医学杂志,2020,30(2):104-108.
[18] PURI B K,TUCKEY G,COWANS L,et al.Association between cardiac atrioventricular conduction and antibodies to chlamydia pneumoniae in fibromyalgia patients[J].Recent Adv Inflamm Allergy Drug Discov,2023,17(2):127-132.
[19] CHAISINANUNKUL N N,CHATSUWAN T,SUWANWELA N C.Association between chlamydia pneumoniae infection and atherosclerosis of cervical or intracranial cerebral vessels in Thai patients[J].Asian Biomedicine,2016,10(S1):S57-S62.
[20] 张茜林,沈逸枫,朱晶,等.血清AST、m-AST水平和m-AST/AST比值在CHD患者及AMI患者术前、术后评估中的价值[J].检验医学,2021,36(5):471-476.
[21] 贺伟.超敏C-反应蛋白与冠心病患者PCI术后支架内血栓形成的影响[J].血栓与止血学,2020,26(2):243-245.
[22] 曹建东,马晓峰,邓勇,等.同型半胱氨酸和C反应蛋白水平与冠状动脉粥样硬化性心脏病患者经皮冠状动脉介入治疗预后的关系研究[J].中国医药,2018,13(7):973-976.
[23] 峁存,曾新春.急性心肌梗死经皮冠状动脉介入术治疗前后血清内皮细胞钙黏蛋白水平、血管生成素-2水平与预后相关性分析[J].陕西医学杂志,2022,51(10):1219-1222.
[24] HAN W,WEI Z,DANG R,et al.Angiotensin-Ⅱ and angiotensin-(1-7)imbalance affects comorbidity of depression and coronary heart disease[J].Peptides,2020,131:170353.
[25] JIAN W,GUAN J H,ZHENG W B,et al.Association between serum angiopoietin-2 concentrations and periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention[J].Aging(Albany NY),2020,12(6):5140-5151.

相似文献/References:

[1]李艳艳,贾 伟△.24h动态心电图在2型糖尿病合并冠心病患者心律诊断中的价值分析[J].陕西医学杂志,2019,(1):61.
[2]汤克虎,高峻峰,任尽平.药物涂层球囊在糖尿病患者冠状动脉小血管病变治疗中的应用研究*[J].陕西医学杂志,2019,(4):432.
[3]马党捐 ,康彦智 ,柴茂林.64排128层螺旋CT冠状动脉成像在冠心病患者诊断中的价值研究*[J].陕西医学杂志,2019,(5):624.
　MA Dangjuan,KANG Yanzhi,CHAI Maolin..Value analysis of 64rows 128slice spiral CT coronary angiography in the diagnosis of patients with coronary heart disease[J].,2019,(5):624.
[4]沈 琳,马文苑.曲美他嗪联合氯吡格雷治疗冠心病心绞痛疗效及对患者心电图、血清超敏C反应蛋白和五聚素3的影响[J].陕西医学杂志,2019,(6):794.
　SHEN Lin,MA Wenyuan.ElectrocardiogramRoom,Therapeutic Effect ofTrimetazidine Combined with Clopidogrel on Angina Pectoris and its Hs-CRP[J].,2019,(5):794.
[5]杨延洁,周慧龙△.不同双抗血小板疗程对冠心病合并房颤PCI术后患者远期预后的影响*[J].陕西医学杂志,2019,(12):1653.
[6]魏 勇,梁 琪,左浩源,等.右美托咪定预处理对冠心病非心脏手术患者心肌的保护作用*[J].陕西医学杂志,2019,(12):1706.
　WEI Yong,LIANG Qi,ZUO Haoyuan,et al.Protective effect of dexmedetomidine preconditioning on myocardium in patients with coronary heart disease undergoing nonheart surgery[J].,2019,(5):1706.
[7]刘玉珊.心外膜脂肪定量及可溶性血栓调节蛋白与冠心病病变程度相关性分析[J].陕西医学杂志,2020,49(1):44.
　LIU Yushan..Correlation between the distribution of epicardial adipose tissue and soluble thrombomodulin and the severity of coronary heart disease[J].,2020,49(5):44.
[8]赵 博,王银谦,王红燕.巨噬细胞移动抑制因子与冠心病关系Meta分析[J].陕西医学杂志,2020,49(1):125.
[9]王亚平,彭春艳,朱名安Δ.冠心病合并代谢综合征患者固醇调节元件结合蛋白表达水平与脂代谢指标相关性研究*[J].陕西医学杂志,2020,49(4):419.
　WANG Yaping,PENG Chunyan,ZHU Mingan..Correlation between the levels of SREBPs and the indicators of lipid metabolism in patients with coronary heart disease complicated with metabolic syndrome[J].,2020,49(5):419.
[10]南格利.冠心病颈动脉超声参数与斑块稳定性及炎症反应水平相关性分析[J].陕西医学杂志,2020,49(4):453.
　NAN Geli..Correlation between carotid ultrasound parameters and plaque stability and inflammatory response in patients with coronary heart disease[J].,2020,49(5):453.
[11]渊 潭,李今朝.老年冠心病患者经皮冠状动脉介入术术后应用低剂量替格瑞洛的可行性及安全性研究[J].陕西医学杂志,2021,50(1):86.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.023]
　YUAN Tan,LI Jinzhao.Feasibility and safety of low dose ticagrelor after percutaneous coronary intervention in elderly patients with coronary heart disease[J].,2021,50(5):86.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.023]

备注/Memo

备注/Memo:
基金项目:河北省医药卫生科技发展计划项目(202103012143)
更新日期/Last Update: 2024-05-06